Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Histogen To Bring CellCeuticals Range To Greater Asia - Happi
Company News

Histogen To Bring CellCeuticals Range To Greater Asia

JAPAN: Histogen Aesthetics has entered into a licensing and distribution agreement with JPGH Co., Ltd. to bring CellCeuticals Regenerative Skin Treatments to Greater Asia.

JPGH, which is run by George Lee and John Paul Mitchell Systems (JPMS) co-founder, chairman and CEO John Paul Dejoria, will target the CellCeuticals line launch to Japan, Singapore, Indonesia, Malaysia, South Korea and Greater China (China, Taiwan, and Hong Kong).

CellCeuticals is a clinically-validated, premium line of skin care products based upon bioactive ingredients, such as proprietary growth factor lipopeptides, that have been shown to enhance skin rejuvenation and reverse the visible signs of aging.

“With regions like Korea and Japan moving to the forefront of stem cell and regenerative medicine, Asia is primed for a sophisticated beauty line based on cellular science,” said Lee. “Our experience and vast network tell us CellCeuticals is the right skin care line at the right time, and we believe it will be extremely well received.”

“Regenerative medicine holds the promise of many advancements in both aesthetic and therapeutic treatments,” said Dejoria. “We are excited to partner with Histogen Aesthetics.”

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters